Author:
Clémence Chevalier,Fouqueray Pascale,Sébastien Bolze
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference19 articles.
1. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
2. CDER (2020b) Guidance for industry: in vitro drug interaction studies — cytochrome P450 enzyme- and transporter-mediated drug interactions.
3. CDER (2020a) Guidance for industry: clinical drug interaction studies — cytochrome p450, enzyme- and transporter-mediated drug interactions.
4. Center for Drug Evaluation and Research (CDER) (2020c) Guidance for industry: Safety testing of drug metabolites. U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD
5. Chevalier C Perrimond-Dauchy S Dubourg J Fouqueray P Bolze S (2020) Lack of drug-drug interaction between cimetidine, a renal transporter inhibitor, and imeglimin, a novel oral antidiabetic drug, in healthy volunteer. Eur J Drug Metab Pharmacokinet DOI: 10.1007/s13318-020-00642-4 [published ahead of print].
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献